Cannabix Technologies Inc. Share Price

Equities

BLO

CA13765L1013

Advanced Medical Equipment & Technology

Market Closed - Canadian Securities Exchange 01:23:51 27/04/2024 am IST 5-day change 1st Jan Change
0.465 CAD -21.19% Intraday chart for Cannabix Technologies Inc. +86.00% +158.33%

Financials

Sales 2022 - Sales 2023 - Capitalization 35.96M 49.15M 3B
Net income 2022 -3M -4.1M -250M Net income 2023 -2M -2.73M -167M EV / Sales 2022 -
Net cash position 2022 8.45M 11.56M 705M Net cash position 2023 6.34M 8.66M 528M EV / Sales 2023 -
P/E ratio 2022
-18.3 x
P/E ratio 2023
-16.8 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 91.38%
More Fundamentals * Assessed data
Dynamic Chart
Cannabix Up 28% as it Says Breath Logix Alcohol Device Delivers "Positive Impact" to Private Monitoring Agency in Montana MT
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands Product Series to Breath Logix CI
Cannabix Technologies Inc. Appoints Phillip Olla to its Board of Directors CI
Cannabix Technologies Inc. Announces Resignation of Kulwant Malhi as President and Director CI
Cannabix Technologies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024 CI
Cannabix Up Over 8% After Reporting Patent for Proprietary Laboratory Drug Analysis Device MT
Cannabix Technologies Inc. Files Patent for Proprietary Laboratory Drug Analysis Device CI
Cannabix Technologies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023 CI
Cannabix Technologies Inc. Completes Initial Electronics Testing on Contactless Alcohol Breathalyzer, Commences International Certification Plans CI
Cannabix Technologies Inc. Reports its Mass Spectrometer Breath Sampler Technology Along with Breath Collection Unit Uses to Quantify Delta-9 THC Levels from Smoking and Edibles in Humans CI
Cannabix Technologies Inc. Reports Earnings Results for the First Quarter Ended July 31, 2023 CI
Cannabix Technologies Inc. Reports Earnings Results for the Full Year Ended April 30, 2023 CI
Cannabix Technologies Inc. Files Breath Sample Capture Patent and Detects Delta- 8 THC in Early Testing CI
Cannabix Technologies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2023 CI
Cannabix Technologies' Breathalyzer Slated for Test Program at Montana Company MT
More news
1 day-21.19%
1 week+86.00%
Current month+111.36%
1 month+121.43%
3 months+126.83%
6 months+111.36%
Current year+158.33%
More quotes
1 week
0.27
Extreme 0.265
0.65
1 month
0.21
Extreme 0.21
0.65
Current year
0.18
Extreme 0.18
0.65
1 year
0.16
Extreme 0.16
0.65
3 years
0.16
Extreme 0.16
1.48
5 years
0.16
Extreme 0.16
2.49
10 years
0.04
Extreme 0.04
3.68
More quotes
Managers TitleAgeSince
Chief Executive Officer 47 05/11/05
Director of Finance/CFO 47 05/11/05
Chief Tech/Sci/R&D Officer - 11/20/11
Members of the board TitleAgeSince
Chief Executive Officer 47 05/11/05
Director of Finance/CFO 47 05/11/05
Director/Board Member 50 04/13/04
More insiders
Date Price Change Volume
26/24/26 0.465 -21.19% 471,559
25/24/25 0.59 +32.58% 516,084
24/24/24 0.445 +12.66% 470,035
23/24/23 0.395 +16.18% 414,943
22/24/22 0.34 +36.00% 135,268

Delayed Quote Canadian Securities Exchange, April 27, 2024 at 01:23 am IST

More quotes
Cannabix Technologies Inc. is a Canada-based developer of marijuana and alcohol breath testing devices. The Company’s primary business is the development of marijuana breathalyzer technology. It is developing technologies to detect Tetrahydrocannabinol (THC) in breath samples for law enforcement, employers and laboratories. In addition, it is developing non-contact alcohol screening devices targeted primarily for workplace settings. The MS Breath Sampler (MSBS) is specialized laboratory hardware developed by the Company to confirm THC in breath from humans. The MSBS is a method for collection of analytes of low volatility from human breath utilizing liquid secondary adsorption. Within the Breath Collection Unit (THC detection), the sample is captured inside a cartridge and loaded into the MSBS. In preliminary testing, the system has detected and confirmed THC in breath out to four hours after smoking with breath samples being stored and analyzed up to two days after sample collection.
Calendar
More about the company